Company record · updated October 7, 2026
Verily Health, Inc. CL B Stock: 3 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs April 30, 2026 to June 30, 2026.
3observations
3source filings
3verified rows
2026-06-30most recent as-of date
Source rails for this company: N-PORT fund mark (3).
Reported by 3 filers: T. Rowe Price Global Stock Fund, T. Rowe Price Health Sciences Fund, Inc., T. Rowe Price Health Sciences Portfolio.
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2026-06-30 | price per share | 11.1478 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 1265988.76 / balance 113564.0 [units / pp] | 000109926326009596 |
| 2026-06-30 | price per share | 11.1478 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 58191.52 / balance 5220.0 [units / pp] | 000109926326009591 |
| 2026-04-30 | price per share | 11.1478 USD | T. Rowe Price Global Stock Fund | VERIFIED | valUSD 126839.67 / balance 11378.0 [units / pp] | 000109926326008016 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price.